🇺🇸 FDA
Patent

US 9975959

Administration of kynurenine depleting enzymes for tumor therapy

granted A61KA61K35/17A61K38/00

Quick answer

US patent 9975959 (Administration of kynurenine depleting enzymes for tumor therapy) held by The Board of Regents of the University of Texas System expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K35/17, A61K38/00, A61K39/3955, A61K47/60